Covalon Technologies (CVALF) Expected to Announce Quarterly Earnings on Friday

Covalon Technologies (OTCMKTS:CVALF) is projected to post its results before the market opens on Friday, February 20th. Analysts expect Covalon Technologies to post earnings of $0.04 per share and revenue of $8.9350 million for the quarter.

Covalon Technologies (OTCMKTS:CVALF) last posted its quarterly earnings results on Thursday, December 11th. The company reported $0.01 EPS for the quarter, topping the consensus estimate of ($0.04) by $0.05. The business had revenue of $6.24 million for the quarter, compared to analyst estimates of $10.49 million. Covalon Technologies had a return on equity of 6.75% and a net margin of 6.25%.

Covalon Technologies Stock Performance

Shares of OTCMKTS:CVALF opened at $1.23 on Friday. The company has a market capitalization of $33.97 million, a price-to-earnings ratio of 24.60 and a beta of 0.54. Covalon Technologies has a 12-month low of $1.18 and a 12-month high of $2.32. The business has a 50-day moving average price of $1.26 and a 200 day moving average price of $1.48.

Covalon Technologies Company Profile

Covalon Technologies Ltd. (OTCMKTS:CVALF) is a Canadian medical device and life sciences company specializing in advanced wound care and infection prevention solutions. Based in Toronto, Ontario, Covalon leverages proprietary photochemical bonding technology to create antimicrobial and anti-adhesion polymer coatings for a range of medical devices and wound dressings. The company’s core focus is on reducing surgical site infections and improving healing outcomes through innovative biomaterials.

The company’s product portfolio comprises hydrogel-based wound dressings and polymer-coated medical device components.